Seeing Is Believing
Currently out of the existing stock ratings of Thomas Flaten, 70 are a BUY (95.89%), 3 are a HOLD (4.11%).
Analyst Thomas Flaten works at LAKE STREET with a stock forecast success ratio of 42.67% fulfilled within 130.67 days on average.
Thomas Flaten’s has documented 139 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AQST, Aquestive Therapeutics at 07-Mar-2024.
Analyst best performing recommendations are on ENSC (ENSYSCE BIOSCIENCES).
The best stock recommendation documented was for ENSC (ENSYSCE BIOSCIENCES) at 12/1/2021. The price target of $960 was fulfilled within 8 days with a profit of $607.2 (172.11%) receiving and performance score of 215.14.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
18
$13.48 (298.23%)
1 months 1 days ago
0/4 (0%)
$13.42 (293.01%)
Buy
4 months 20 days ago
1/1 (100%)
$-45.93 (-79.19%)
189
Buy
19
$14.48 (320.35%)
31
11 months 1 days ago
0/3 (0%)
$12.8 (206.45%)
Which stock is Thomas Flaten is most bullish on?
Which stock is Thomas Flaten is most reserved on?
What Year was the first public recommendation made by Thomas Flaten?